1
|
Murbach TS, Glávits R, Endres JR, Hirka G, Vértesi A, Béres E, Pasics Szakonyiné I. An evaluation of the genotoxicity and 90-day repeated dose oral toxicity in rats of Porphyridium purpureum. J Appl Toxicol 2024; 44:1616-1632. [PMID: 38950973 DOI: 10.1002/jat.4665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2024] [Revised: 06/05/2024] [Accepted: 06/10/2024] [Indexed: 07/03/2024]
Abstract
Interest in microalgae products for use in food is increasing, as demands for sustainable and cost-effective food choices grow due to the escalating global population and increase in climate-related struggles with agriculture. Toxicological assessments of some species of microalgae have been conducted, but there were little data available for the oral consumption of the red microalgae Porphyridium purpureum and no data on genotoxicity. This article articulates a genotoxicity assessment and a 90-day repeated dose oral toxicity study in rats performed according to OECD guidelines. Under the experimental conditions applied, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used in the bacterial reverse mutation test. Similarly, the test item did not induce structural chromosomal aberrations in V79 hamster lung cells. The test item also did not cause chromosomal damage in bone marrow of mice in the mammalian micronucleus test. The no observed adverse effect level (NOAEL) of the 90-day repeated dose oral toxicity study in rats was determined to be the highest dose tested, 3000 mg/kg bw/day. These data add to the body of evidence regarding the safety of P. purpureum for human consumption.
Collapse
|
2
|
Currais A, Raschke W, Maher P. CMS121, a Novel Drug Candidate for the Treatment of Alzheimer's Disease and Age-Related Dementia. J Alzheimers Dis 2024; 101:S179-S192. [PMID: 39422940 DOI: 10.3233/jad-231062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2024]
Abstract
Old age is the major risk factor for sporadic Alzheimer's disease (AD). However, old age-related changes in brain physiology have generally not been taken into consideration in developing drug candidates for the treatment of AD. This is at least partly because the role of these age-related processes in the development and progression of AD are still not well understood. Nevertheless, we and others have described an association between the oxytosis/ferroptosis non-apoptotic regulated cell death pathway and aging. Based on this association, we incorporated protection against this pathway as part of a cell-based phenotypic screening approach to identify novel drug candidates for the treatment of AD. Using this approach, we identified the fisetin derivative CMS121 as a potent neuroprotective molecule that is able to maintain cognitive function in multiple pre-clinical models of AD. Furthermore, we identified a key target of CMS121 as fatty acid synthase, a protein which had not been previously considered in the context of AD. Herein, we provide a comprehensive description of the development of CMS121, its preclinical activities, and the results of the toxicology testing that led to its IND approval.
Collapse
Affiliation(s)
| | | | - Pamela Maher
- Salk Institute for Biological Studies, La Jolla, CA, USA
| |
Collapse
|
3
|
Murbach TS, Glávits R, Jayasena S, Moghadam Maragheh N, Endres JR, Hirka G, Goodman RE, Vértesi A, Béres E, Pasics Szakonyiné I. Toxicology and digestibility of Chlamydomonas debaryana green algal biomass. J Appl Toxicol 2023. [PMID: 36680512 DOI: 10.1002/jat.4438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2022] [Revised: 12/29/2022] [Accepted: 01/17/2023] [Indexed: 01/22/2023]
Abstract
There is an economic interest, both for food security and for the non-meat-eating population, in the development of novel, sustainable sources of high-quality protein. The green algae Chlamydomonas reinhardtii has already been developed for this purpose, and the closely related species, Chlamydomonas debaryana, is a complementary source that also presents some additional advantages, such as reduced production cost. To determine whether C. debaryana may have a similar safety profile to that of C. reinhardtii, a wild type strain was obtained, designated TS04 after confirmation of its identity, and subjected to a battery of preclinical studies. Genetic toxicity was evaluated using a bacterial reverse mutation test, an in vitro mammalian chromosomal aberration test, and an in vivo mammalian micronucleus test in a mouse model. No genotoxic potential (e.g., mutagenicity and clastogenicity) was observed in these tests under the employed conditions up to maximum recommended concentrations or doses. To assess general toxicity, a 90-day repeated-dose oral toxicity study was conducted in rats. No mortality or adverse effects were observed, and no target organs were identified up to the maximum feasible dose, due to solubility, of 4,000 mg/kg bw/day. The no-observed-adverse-effect level was determined as the highest dose tested. A digestibility study in simulated gastric fluid was conducted and determined that TS04 has low allergenic potential, exhibiting rapid digestion of proteins. Due to the negative results of our evaluation, it is reasonable to proceed with further development and additional investigations to contribute towards a safety assessment of the proposed use in food for human consumption.
Collapse
Affiliation(s)
| | | | - Shyamali Jayasena
- Food Allergy Research and Resource Program (FARRP), Department of Food Science and Technology, University of Nebraska, Lincoln, Nebraska, USA
| | - Niloofar Moghadam Maragheh
- Food Allergy Research and Resource Program (FARRP), Department of Food Science and Technology, University of Nebraska, Lincoln, Nebraska, USA
| | | | - Gábor Hirka
- Toxi-Coop Zrt., Budapest, Hungary.,Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary
| | - Richard E Goodman
- Food Allergy Research and Resource Program (FARRP), Department of Food Science and Technology, University of Nebraska, Lincoln, Nebraska, USA
| | - Adél Vértesi
- Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary
| | - Erzsébet Béres
- Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary
| | | |
Collapse
|
4
|
Modica V, Glávits R, Murbach TS, Endres JR, Hirka G, Vértesi A, Béres E, Pasics Szakonyiné I. Toxicological evaluation of protein powder derived from Cupriavidus necator. J Appl Toxicol 2023; 43:887-912. [PMID: 36598355 DOI: 10.1002/jat.4432] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2022] [Revised: 12/29/2022] [Accepted: 12/29/2022] [Indexed: 01/05/2023]
Abstract
Microorganisms have the potential to produce nutrient-rich products that can be consumed as food or feed. The protein-rich powder derived from heat treatment of the whole-cell biomass of polyhydroxybutyrate-deficient Cupriavidus necator, a metabolically versatile organism that uses elements found in the air, is an example of such a product. To assess the safety of the protein powder for use as a nutritional ingredient in human food, in accordance with internationally accepted standards, its genotoxic potential and repeated-dose oral toxicity were investigated. A bacterial reverse mutation test, an in vitro mammalian chromosomal aberration test, and an in vivo mammalian micronucleus test were performed. No evidence of mutagenicity or genotoxicity was found. Additionally, a 90-day repeated-dose oral toxicity study in rats was completed, in which a total of 100 male and female Wistar rats were exposed by gavage to daily doses of 1000, 2000, or 3000 mg/kg bw/day of the test material. Following 90 days of continuous exposure, no mortality or treatment-related adverse effects were observed and no target organs were identified. Therefore, a no observed adverse effect level was determined at 3000 mg/kg bw/day, the highest dose tested.
Collapse
Affiliation(s)
- Vickie Modica
- AIBMR Life Sciences, Inc., 1425 Broadway, Suite 458, Seattle, Washington, 98122, USA
| | - Róbert Glávits
- Toxi-Coop Zrt., Berlini utca 47-49, H-1045, Budapest, Hungary
| | - Timothy S Murbach
- AIBMR Life Sciences, Inc., 1425 Broadway, Suite 458, Seattle, Washington, 98122, USA
| | - John R Endres
- AIBMR Life Sciences, Inc., 1425 Broadway, Suite 458, Seattle, Washington, 98122, USA
| | - Gábor Hirka
- Toxi-Coop Zrt., Berlini utca 47-49, H-1045, Budapest, Hungary.,Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary
| | - Adél Vértesi
- Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary
| | - Erzsébet Béres
- Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary
| | | |
Collapse
|
5
|
Modica V, Glávits R, Murbach TS, Endres JR, Hirka G, Vértesi A, Béres E, Szakonyiné IP. A toxicological evaluation of 8–28 nm gold nanocrystals. Food Chem Toxicol 2022; 161:112844. [DOI: 10.1016/j.fct.2022.112844] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2021] [Revised: 01/24/2022] [Accepted: 01/28/2022] [Indexed: 10/19/2022]
|
6
|
Murbach TS, Glávits R, Maragheh NM, Endres JR, Hirka G, Goodman RE, Lu G, Vértesi A, Béres E, Szakonyiné IP. Evaluation of the genotoxic potential of protoporphyrin IX and the safety of a protoporphyrin IX-rich algal biomass. J Appl Toxicol 2022; 42:1253-1275. [PMID: 35104912 DOI: 10.1002/jat.4293] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2022] [Revised: 01/18/2022] [Accepted: 01/26/2022] [Indexed: 11/06/2022]
Abstract
Chlamydomonas reinhardtii is a nonpathogenic, nontoxigenic green algae used as a sustainable source of protein in foods. In order to mimic meat-like qualities, a strain rich in protoporphyrin IX (PPIX), an endogenous heme/chlorophyll precursor, was developed using an evolution and selection strategy, and investigations were carried out to evaluate the safety of the novel strain, C. reinhardtii (red), strain TAI114 (TAI114). Digestibly and proteomic evaluations were conducted to determine whether any potentially allergenic or toxic proteins occurred as the result of the mutation process. The genotoxic potential of pure PPIX was evaluated using a bacterial reverse mutation test, an in vitro mammalian chromosomal aberration test, and an in vivo mammalian micronucleus test. Finally, the novel TAI114 biomass was evaluated for general toxicity and identification of target organs in a 90-day repeated-dose oral toxicity study in rats. All proteins were rapidly degraded in pepsin at pH 2.0 suggesting low allergenic potential. The proteomic evaluation indicated that TAI114 biomass contains typical C. reinhardtii proteins. PPIX was unequivocally negative for genotoxic potential and no target organs or adverse effects were observed in rats up to the maximum feasible dose of 4000 mg/kg bw/day TAI114 biomass, which was determined to be the no-observed-adverse-effect-level (NOAEL). These results support the further development and risk characterization of TAI114 biomass as a novel ingredient for use in the meat analogue category of food.
Collapse
Affiliation(s)
- Timothy S Murbach
- AIBMR Life Sciences, Inc., 1425 Broadway, Suite 458, Seattle, WA, USA
| | - Róbert Glávits
- Toxi-Coop Zrt., Berlini utca 47-49, H-1045, Budapest, Hungary
| | - Niloofar Moghadam Maragheh
- Goodman Laboratory, Food Allergy Research and Resource Program (FARRP), University of Nebraska, Dept. of Food Science & Technology, Lincoln, NE, USA
| | - John R Endres
- AIBMR Life Sciences, Inc., 1425 Broadway, Suite 458, Seattle, WA, USA
| | - Gábor Hirka
- Toxi-Coop Zrt., Berlini utca 47-49, H-1045, Budapest, Hungary.,Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary
| | - Richard E Goodman
- Goodman Laboratory, Food Allergy Research and Resource Program (FARRP), University of Nebraska, Dept. of Food Science & Technology, Lincoln, NE, USA
| | - Guihua Lu
- Triton Algae Innovations, 11760 Sorrento Valley Road, Suite R, San Diego, California, USA
| | - Adél Vértesi
- Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary
| | - Erzsébet Béres
- Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary
| | | |
Collapse
|
7
|
Cornforth MN, Bedford JS, Bailey SM. Destabilizing Effects of Ionizing Radiation on Chromosomes: Sizing up the Damage. Cytogenet Genome Res 2021; 161:328-351. [PMID: 34488218 DOI: 10.1159/000516523] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2020] [Accepted: 02/16/2021] [Indexed: 11/19/2022] Open
Abstract
For long-term survival and evolution, all organisms have depended on a delicate balance between processes involved in maintaining stability of their genomes and opposing processes that lead toward destabilization. At the level of mammalian somatic cells in renewal tissues, events or conditions that can tip this balance toward instability have attracted special interest in connection with carcinogenesis. Mutations affecting DNA (and its subsequent repair) would, of course, be a major consideration here. These may occur spontaneously through endogenous cellular processes or as a result of exposure to mutagenic environmental agents. It is in this context that we discuss the rather unique destabilizing effects of ionizing radiation (IR) in terms of its ability to cause large-scale structural rearrangements to the genome. We present arguments supporting the conclusion that these and other important effects of IR originate largely from microscopically visible chromosome aberrations.
Collapse
Affiliation(s)
- Michael N Cornforth
- Department of Radiation Oncology, University of Texas Medical Branch, Galveston, Texas, USA
| | - Joel S Bedford
- Department of Environmental & Radiological Health Sciences, Colorado State University, Fort Collins, Colorado, USA
| | - Susan M Bailey
- Department of Environmental & Radiological Health Sciences, Colorado State University, Fort Collins, Colorado, USA
| |
Collapse
|
8
|
Francisco LFV, Baldivia DDS, Crispim BDA, Klafke SMFF, de Castilho PF, Viana LF, dos Santos EL, de Oliveira KMP, Barufatti A. Acute Toxic and Genotoxic Effects of Aluminum and Manganese Using In Vitro Models. TOXICS 2021; 9:toxics9070153. [PMID: 34208861 PMCID: PMC8309840 DOI: 10.3390/toxics9070153] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/27/2021] [Revised: 05/02/2021] [Accepted: 05/03/2021] [Indexed: 12/12/2022]
Abstract
The objective of this study was to use the same concentrations of aluminum (Al) and manganese (Mn) detected previously in groundwater above those permitted by Brazilian law and assess their cytotoxic and genotoxic effects in hamster ovary cell lines and their mutagenic effects through the Salmonella microsome assay. Chinese hamster ovary (CHO) and CHO-XRS5 cells were treated with different concentrations of Al and Mn (0.2 to 2.0 mg/L and 0.1 to 3.0 mg/L, respectively). The Ames test was used to analyze the concentrations of Al and Mn ranging from 0.025 to 1.0 mg/L and 0.0125 to 1.5 mg/L, respectively. Both metals showed cytotoxic effects on both cell lines and two bacterial strains (TA98 and TA100). The genotoxic effects of the highest concentrations of Al and Mn in cell lines showed nuclear buds, micronuclei, and DNA damage; however, none of the concentrations showed a positive mutagenic response in the Ames test. This is one of the few studies to demonstrate the cytotoxic effects of Al and Mn through the Ames test. In addition, the metals caused genomic instability in cell lines. Therefore, this study may help hasten the review of established regulatory standards for human consumption of groundwater.
Collapse
Affiliation(s)
- Luiza Flavia Veiga Francisco
- Faculty of Exact Sciences and Technology, Federal University of Grande Dourados, Dourados 79.804-970, Mato Grosso do Sul, Brazil;
| | - Debora da Silva Baldivia
- Faculty of Biological and Environmental Sciences, Federal University of Grande Dourados, Dourados 79.804-970, Mato Grosso do Sul, Brazil; (D.d.S.B.); (B.d.A.C.); (S.M.F.F.K.); (L.F.V.); (E.L.d.S.); (K.M.P.d.O.)
| | - Bruno do Amaral Crispim
- Faculty of Biological and Environmental Sciences, Federal University of Grande Dourados, Dourados 79.804-970, Mato Grosso do Sul, Brazil; (D.d.S.B.); (B.d.A.C.); (S.M.F.F.K.); (L.F.V.); (E.L.d.S.); (K.M.P.d.O.)
| | - Syla Maria Farias Ferraz Klafke
- Faculty of Biological and Environmental Sciences, Federal University of Grande Dourados, Dourados 79.804-970, Mato Grosso do Sul, Brazil; (D.d.S.B.); (B.d.A.C.); (S.M.F.F.K.); (L.F.V.); (E.L.d.S.); (K.M.P.d.O.)
| | - Pamella Fukuda de Castilho
- Postgraduate Program in Health Science, Federal University of Grande Dourados, Dourados 79.804-970, Mato Grosso do Sul, Brazil;
| | - Lucilene Finoto Viana
- Faculty of Biological and Environmental Sciences, Federal University of Grande Dourados, Dourados 79.804-970, Mato Grosso do Sul, Brazil; (D.d.S.B.); (B.d.A.C.); (S.M.F.F.K.); (L.F.V.); (E.L.d.S.); (K.M.P.d.O.)
| | - Edson Lucas dos Santos
- Faculty of Biological and Environmental Sciences, Federal University of Grande Dourados, Dourados 79.804-970, Mato Grosso do Sul, Brazil; (D.d.S.B.); (B.d.A.C.); (S.M.F.F.K.); (L.F.V.); (E.L.d.S.); (K.M.P.d.O.)
| | - Kelly Mari Pires de Oliveira
- Faculty of Biological and Environmental Sciences, Federal University of Grande Dourados, Dourados 79.804-970, Mato Grosso do Sul, Brazil; (D.d.S.B.); (B.d.A.C.); (S.M.F.F.K.); (L.F.V.); (E.L.d.S.); (K.M.P.d.O.)
| | - Alexeia Barufatti
- Faculty of Biological and Environmental Sciences, Federal University of Grande Dourados, Dourados 79.804-970, Mato Grosso do Sul, Brazil; (D.d.S.B.); (B.d.A.C.); (S.M.F.F.K.); (L.F.V.); (E.L.d.S.); (K.M.P.d.O.)
- Correspondence: ; Tel.: +55-67-3410-2255
| |
Collapse
|
9
|
Murbach TS, Glávits R, Endres JR, Hirka G, Vértesi A, Béres E, Szakonyiné IP. A toxicological evaluation of lithium orotate. Regul Toxicol Pharmacol 2021; 124:104973. [PMID: 34146638 DOI: 10.1016/j.yrtph.2021.104973] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2021] [Accepted: 06/11/2021] [Indexed: 11/27/2022]
Abstract
Lithium orotate, the salt of lithium and orotic acid, has been marketed for decades as a supplemental source of lithium with few recorded adverse events. Nonetheless, there have been some concerns in the scientific literature regarding orotic acid, and pharmaceutical lithium salts are known to have a narrow therapeutic window, albeit, at lithium equivalent therapeutic doses 5.5-67 times greater than typically recommended for supplemental lithium orotate. To our knowledge, the potential toxicity of lithium orotate has not been investigated in preclinical studies; thus, we conducted a battery of genetic toxicity tests and an oral repeated-dose toxicity test in order to further explore its safety. Lithium orotate was not mutagenic or clastogenic in bacterial reverse mutation and in vitro mammalian chromosomal aberration tests, respectively, and did not exhibit in vivo genotoxicity in a micronucleus test in mice. In a 28-day, repeated-dose oral toxicity study, rats were administered 0, 100, 200, or 400 mg/kg body weight/day of lithium orotate by gavage. No toxicity or target organs were identified; therefore, a no observed adverse effect level was determined as 400 mg/kg body weight/day. These results are supportive of the lack of a postmarket safety signal from several decades of human consumption.
Collapse
Affiliation(s)
- Timothy S Murbach
- AIBMR Life Sciences, Inc., 1425 Broadway, Suite 458, Seattle, WA, 98122, USA.
| | - Róbert Glávits
- Toxi-Coop Zrt., Berlini utca 47-49, H-1045, Budapest, Hungary.
| | - John R Endres
- AIBMR Life Sciences, Inc., 1425 Broadway, Suite 458, Seattle, WA, 98122, USA.
| | - Gábor Hirka
- Toxi-Coop Zrt., Berlini utca 47-49, H-1045, Budapest, Hungary; Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary.
| | - Adél Vértesi
- Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary.
| | - Erzsébet Béres
- Toxi-Coop Zrt., Arácsi út 97, 8230, Balatonfüred, Hungary.
| | | |
Collapse
|
10
|
A toxicological evaluation of geranylgeraniol. Regul Toxicol Pharmacol 2021; 124:104975. [PMID: 34144118 DOI: 10.1016/j.yrtph.2021.104975] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2021] [Revised: 05/25/2021] [Accepted: 06/11/2021] [Indexed: 11/23/2022]
Abstract
Geranylgeraniol (GGOH) is an isoprenoid compound found in annatto seeds and an intermediate of the mevalonate pathway found within organisms serving various functions. Toxicological studies on its safety profile are not readily available. To assess the safety of GGOH, a molecularly distilled, food grade annatto oil, consisting of approximately 80% trans-GGOH, was subjected to a bacterial reverse mutation test, an in vitro mammalian chromosomal aberration test, and an in vivo mammalian micronucleus test in order to investigate its genotoxic potential and a 90-day repeated-dose oral toxicity study in rats in order to investigate its potential subchronic toxicity and identify any target organs. No evidence of mutagenicity or genotoxic activity was observed under the applied test systems. In the 90-day study, male and female Hsd. Han Wistar rats were administered daily doses of 0, 725, 1450, and 2900 mg/kg bw/day by gavage. Treatment-related adverse effects were observed in the forestomach at all dose levels and in the liver at the intermediate- and high-dose levels. Based on these results, the lowest observed adverse effect level (LOAEL) for local effects and the no observed adverse effect level (NOAEL) for systemic effects were determined as 725 mg/kg bw/day.
Collapse
|
11
|
Murbach TS, Glávits R, Endres JR, Clewell AE, Hirka G, Vértesi A, Béres E, Pasics Szakonyiné I. A toxicological evaluation of a fulvic and humic acids preparation. Toxicol Rep 2020; 7:1242-1254. [PMID: 32995299 PMCID: PMC7505752 DOI: 10.1016/j.toxrep.2020.08.030] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2020] [Revised: 08/25/2020] [Accepted: 08/27/2020] [Indexed: 01/21/2023] Open
Abstract
Toxicological evaluations of blk. 333 according to OECD guidelines were negative. Blk. 333 was not mutagenic in vitro and showed no in vivo genotoxic activity. The NOAEL of the 90-day study was 2000 mg/kg bw/d blk. 333—the highest dose tested. No target organs or treatment-related toxicological effects were identified. Our results are relevant to a safety assessment of human ingestion of blk. 333.
Humic substances are ubiquitous in soils and waters. These complex superstructures are derived from the decomposition of dead plant and animal matter and are vital to soil health. Their heterogenous composition is specific to their site of origin and is comprised of weakly bound aggregates of small organic compounds that can sequester minerals and make them available to plants. As such, they may possess potential nutritional value for humans, and extractions of fulvic and humic acids can be produced that could be suitable for such purposes. For this reason, we evaluated the toxicological profile of a specific preparation (blk. 333) of fulvic and humic acids derived from a lignite deposit in Alberta, Canada and found it to lack genotoxic potential in a bacterial reverse mutation test, in vitro mammalian chromosomal aberration test, and in vivo mammalian micronucleus test. No general or organ toxicity was observed in Wistar rats following 90 days of continuous exposure, and a no observed adverse effect level (NOEAL) was determined at 2000 mg/kg bw/day, the highest tested dose. Our results suggest the feasibility of further evaluation for development of the preparation as a nutritional supplement in food.
Collapse
Key Words
- ANOVA, analysis of variance
- CDFA, California Department of Food and Agricultural
- Cl-HA, chlorinated humic acid
- DME, Dulbecco’s modified Eagle’s
- EFSA, European Food Safety Authority
- FA, fulvic acid
- FOB, functional observation battery
- Fulvic acid
- GLP, good laboratory practice
- HA, humic acid
- Humic acid
- MPCE, micronucleated polychromatic erythrocytes
- NOAEL
- NOAEL, no observed adverse effect level
- O3-HA, ozonated humic acid
- O3/Cl2-HA, ozonated and chlorinated humic acid
- OECD, Organisation for Economic Co-operation and Development
- S9, post mitochondrial supernatant S9-mix Phenobarbital/β-naphthoflavone-induced rat liver S9 metabolic activation system
- SCE, sister chromatid exchange
- SD, Sprague-Dawley
- SOP, standard operating procedure
- SPF, specific pathogen-free
- Safety
- TG, test guideline
- TSH, thyroid stimulating hormone
- Toxicity
- blk. 333
- fT4, free thyroxine
Collapse
Affiliation(s)
- Timothy S Murbach
- AIBMR Life Sciences, Inc., 1425 Broadway, Suite 458, Seattle, WA 98122, USA
| | - Róbert Glávits
- Toxi-Coop Zrt., Berlini utca 47-49, H-1045 Budapest, Hungary
| | - John R Endres
- AIBMR Life Sciences, Inc., 1425 Broadway, Suite 458, Seattle, WA 98122, USA
| | - Amy E Clewell
- AIBMR Life Sciences, Inc., 1425 Broadway, Suite 458, Seattle, WA 98122, USA
| | - Gábor Hirka
- Toxi-Coop Zrt., Berlini utca 47-49, H-1045 Budapest, Hungary.,Toxi-Coop Zrt., Arácsi út 97, 8230 Balatonfüred, Hungary
| | - Adél Vértesi
- Toxi-Coop Zrt., Arácsi út 97, 8230 Balatonfüred, Hungary
| | - Erzsébet Béres
- Toxi-Coop Zrt., Arácsi út 97, 8230 Balatonfüred, Hungary
| | | |
Collapse
|
12
|
Shirinzadeh H, Neuhaus E, Ince Erguc E, Tascioglu Aliyev A, Gurer-Orhan H, Suzen S. New indole-7-aldehyde derivatives as melatonin analogues; synthesis and screening their antioxidant and anticancer potential. Bioorg Chem 2020; 104:104219. [PMID: 32916391 DOI: 10.1016/j.bioorg.2020.104219] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2020] [Revised: 08/06/2020] [Accepted: 08/20/2020] [Indexed: 12/30/2022]
Abstract
Over the last decade, there has been substantial interest in the use of melatonin (MLT) and MLT-like compounds in the treatment of several diseases. MLT can scavenge different reactive oxygen species and can also stimulate the synthesis of antioxidant enzymes. Our ongoing study relies on changing the groups in the different modifiable sites of the indole ring to increase the antioxidant activity. In this study a new approach for substitution of indole ring as indole based MLT analogue was proposed. We report the synthesis and characterization of a series of new indole-7-aldehyde hydrazide/hydrazone derivatives as indole-based MLT analogues. Anticancer potential of the compounds were evaluated both by their antioxidant and CYP1 inhibitory activities. In vitro antioxidant capacity of the compounds was investigated both in a cell-based (DCFH assay) and a cell-free (DPPH assay) assay. Potential inhibitory effects of the compounds on CYP1 catalytic activity were investigated via EROD assay. Cytotoxic activity of the compounds was further evaluated by the MTT assay in CHO-K1 cells. MLT analogues having an o-halogenated aromatic moiety exhibited effective antioxidant properties without having any cytotoxic effect. In conclusion, MLT derivatives represent promising scaffolds for discovery of effective antioxidant agents.
Collapse
Affiliation(s)
- Hanif Shirinzadeh
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Erzincan Binali YildirimUniversity, Yanlızbag Yerleskesi, 24100 Erzincan, Turkey.
| | - Eddy Neuhaus
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, Tandogan-06100, Ankara, Turkey
| | - Elif Ince Erguc
- Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Ege University, 35040 Izmir, Turkey; Department of Pharmaceutical Toxicology, Faculty of Pharmacy, İzmir Katip Celebi University, 35620 Izmir, Turkey
| | - Alev Tascioglu Aliyev
- Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Ege University, 35040 Izmir, Turkey
| | - Hande Gurer-Orhan
- Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Ege University, 35040 Izmir, Turkey
| | - Sibel Suzen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, Tandogan-06100, Ankara, Turkey
| |
Collapse
|
13
|
Preece KE, Glávits R, Murbach T, Endres JR, Hirka G, Vértesi A, Béres E, Szakonyiné IP. A toxicological evaluation of monomethylsilanetriol (MMST) stabilized in acacia gum, a novel silicon preparation. Regul Toxicol Pharmacol 2020; 117:104782. [PMID: 32905813 DOI: 10.1016/j.yrtph.2020.104782] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2020] [Revised: 06/25/2020] [Accepted: 09/01/2020] [Indexed: 10/23/2022]
Abstract
Monomethylsilanetriol (MMST), a silicon-containing compound, has been sold in dietary supplements. However, toxicological studies on its safety profile are not readily available. To assess the safety of MMST stabilized in acacia gum, a novel delivery form of MMST, in accordance with internationally accepted standards, the genotoxic potential and repeated-dose oral toxicity of Living Silica® Acacia Gum Stabilized Monomethylsilanetriol (formerly known as Orgono Acacia Gum Powder®), a food grade product consisting of 80 ± 10% acacia gum and 2.8% (SD ± 10%) elemental silicon from MMST, was investigated. A bacterial reverse mutation test, an in vitro mammalian chromosomal aberration test, an in vivo mammalian micronucleus test, and a 90-day repeated-dose oral toxicity study in rats were performed. No evidence of mutagenicity or genotoxic activity was observed under the applied test systems. In the 90-day study, male and female Hsd.Han Wistar rats were administered daily doses of 0, 500, 1000, and 2000 mg/kg bw/day by gavage. No mortality or treatment-related adverse effects were observed, and no target organs were identified. Therefore, the no observed adverse effects level (NOAEL) was determined as 2000 mg/kg bw/day (201 mg MMST/kg bw/day), the highest dose tested.
Collapse
Affiliation(s)
- Kayla E Preece
- AIBMR Life Sciences, Inc, 1425 Broadway, Suite 458, Seattle, WA, 98122, USA.
| | - Róbert Glávits
- Toxi-Coop Zrt, Magyar Jakobinusok tere 4/B, H-1122, Budapest, Hungary.
| | - Tim Murbach
- AIBMR Life Sciences, Inc, 1425 Broadway, Suite 458, Seattle, WA, 98122, USA.
| | - John R Endres
- AIBMR Life Sciences, Inc, 1425 Broadway, Suite 458, Seattle, WA, 98122, USA.
| | - Gábor Hirka
- Toxi-Coop Zrt, Magyar Jakobinusok tere 4/B, H-1122, Budapest, Hungary.
| | - Adél Vértesi
- Toxi-Coop Zrt, Magyar Jakobinusok tere 4/B, H-1122, Budapest, Hungary.
| | - Erzsébet Béres
- Toxi-Coop Zrt, Magyar Jakobinusok tere 4/B, H-1122, Budapest, Hungary.
| | | |
Collapse
|
14
|
Ladics GS, Han KH, Jang MS, Park H, Marshall V, Dersjant-Li Y, Sewalt VJ. Safety evaluation of a novel variant of consensus bacterial phytase. Toxicol Rep 2020; 7:844-851. [PMID: 32714839 PMCID: PMC7372152 DOI: 10.1016/j.toxrep.2020.07.004] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2020] [Revised: 07/09/2020] [Accepted: 07/11/2020] [Indexed: 01/08/2023] Open
Abstract
90-day oral and genetic toxicology studies were conducted on a next generation bacterial biosynthetic 6-phytase as an animal feed additive. No test article-related adverse effects were observed and a NOAEL was established as 1000 mg Total Organic Solids/kg bw/day. A margin of safety value of 1613 was calculated based on the NOAEL and an estimate of broiler feed consumption. Data support the safety of PhyG as an animal feed additive.
A 90-day subchronic oral toxicity study was conducted to evaluate the safety of a consensus bacterial phytase variant 6-phytase (PhyG) for use as an animal feed additive. This phytase is produced by fermentation with a fungal (Trichoderma reesei) production strain expressing a biosynthetic variant of a consensus bacterial phytase gene assembled via ancestral reconstruction with sequence bias for the phytase from Buttiauxella sp. Rats were administered PhyG daily via oral gavage at dose-levels of 0 (distilled water), 250, 500 or 1000 mg total organic solids (TOS)/kg bodyweight (bw)/day (equivalent to 0, 112,500, 225,000 and 450,000 phytase units (FTU)/kg bw/day, respectively). No test article-related adverse effects were observed. A no-observed-adverse-effect level (NOAEL) for PhyG was established as 1000 mg TOS/kg bw/day, the highest test concentration. Based on this NOAEL and an estimate of broiler consumption determined from the proposed inclusion of the phytase in feed at the maximum recommended level (4000 FTU/kg), a margin of safety value of 1613 was calculated. Results of in vitro genotoxicity testing and in silico protein toxin evaluation further confirmed PhyG to be non-genotoxic and not likely to be a protein toxin upon consumption. These data support the safety of PhyG as an animal feed additive.
Collapse
Key Words
- BLAST, basic local alignment search tool
- DM, dry matter
- FTU, phytase units
- Genetic toxicology
- IP6, myo-inositol hexaphosphate
- MCP, monocalcium phosphate
- NOAEL
- NOAEL, no-observed-adverse-effect-level
- OECD, The Organisation for Economic Co-operation and Development
- Oral gavage
- Phytase
- SSL, safe strain lineage
- Subchronic study
- TOS, total organic solids
- UFC, ultra-filtered concentrate
- bw, body weight
Collapse
Affiliation(s)
- Gregory S Ladics
- DuPont Nutrition and Biosciences, 200 Powder Mill Road, Wilmington, DE, USA
| | - Kang-Hyun Han
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea
| | - Min S Jang
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea
| | - Heejin Park
- Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea
| | - Valerie Marshall
- DuPont Nutrition and Biosciences, 1501 Larkin Center Drive, Midland, Michigan, USA
| | - Yueming Dersjant-Li
- DuPont Animal Nutrition, DuPont Nutrition and Biosciences, Archimedesweg, 30, 2333 CN, Leiden, the Netherlands
| | - Vincent J Sewalt
- DuPont Nutrition and Biosciences, 925 Page Mill Road, Palo Alto, CA, 94304, USA
| |
Collapse
|
15
|
A Toxicological Evaluation of Methylliberine (Dynamine®). J Toxicol 2019; 2019:4981420. [PMID: 31911801 PMCID: PMC6930730 DOI: 10.1155/2019/4981420] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2019] [Accepted: 08/23/2019] [Indexed: 12/27/2022] Open
Abstract
Methylliberine (CAS 51168-26-4), a methoxiuric acid, is a caffeine metabolite present at low levels in various Coffea plants; however, very little has been published regarding this compound and we could find no toxicological data in the public domain. Therefore, we undertook the toxicological investigation of a pure, synthetic form of methylliberine in order to evaluate its potential health hazards as a food ingredient. A (1) bacterial reverse mutation test, (2) in vitro mammalian chromosomal aberration test, (3) in vivo mammalian micronucleus test, and (4) 90-day repeated-dose oral toxicity study in rats with a 28-day recovery period were conducted. No in vitro mutagenic or clastogenic activity was observed in the presence or absence of metabolic activation up to the maximum OECD recommended test concentrations. No genotoxicity was observed in the mammalian micronucleus study up to the highest dose tested of 700 mg/kg bw. In the 90-day study, methylliberine was administered to Han:WIST rats at doses of 0, 75, 112, 150, 187, and 225 mg/kg bw/day. No mortality or morbidity was observed and no toxicologically relevant clinical effects or effects on clinical pathology parameters were observed. In male animals, test item-related effects on body weight and sexual organs, which were not reversible after a 28-day recovery period without treatment, were observed in the high-dose group. Body weight development was also slightly and reversibly depressed in the 187 mg/kg bw/day male group. No toxicological effects were observed in females. The NOAEL for females was determined to be 225 mg/kg bw/day, the highest dose tested, while the NOAEL for males was determined to be 150 mg/kg bw/day. Future studies are encouraged to corroborate the safety, and assess efficacy, of methylliberine in humans.
Collapse
|
16
|
Tripathi R, Banji D, Tripathi P. Evaluation of mutagenic and anti-mutagenic potential of alpha-lipoic acid by chromosomal aberration assay in mice. Drug Chem Toxicol 2019; 43:378-382. [PMID: 31072146 DOI: 10.1080/01480545.2019.1606231] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
This study investigated both the mutagenicity and anti-mutagenicity of alpha-lipoic acid (ALA) in the bone marrow cells of mice using a chromosomal aberration assay. Cyclophosphamide (CP) 40 mg/kg was used as a clastogen in the positive control, and a vehicle-treated negative control group was also included. Multiple dose levels (15, 30, and 100 mg/kg of ALA) were given by intraperitoneal injection (IP) alone and in combination with CP (CP was administered 1 h prior to ALA). Bone marrow samples were collected 12 and 24 h after drug administration. The results demonstrated a significant increase in the frequency of chromosomal aberrations (CA) in bone marrow cells with depressions in the mitotic index (MI) of the positive control group of mice. However, in the groups of mice treated with different doses of ALA in the presence of CP, the percentages of CA decreased significantly with increases in mitotic activity. The results also indicate that ALA given alone in different doses had no mutagenic effect on mouse bone marrow cells. ALA has a dose and time-dependent protective effect against the mutagenicity induced by CP.
Collapse
Affiliation(s)
- Rina Tripathi
- Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, KSA
| | - David Banji
- Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, KSA
| | - Pankaj Tripathi
- Department of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan, KSA
| |
Collapse
|
17
|
Palmer PA, Bryson JA, Clewell AE, Endres JR, Hirka G, Vértesi A, Béres E, Glávits R, Szakonyiné IP. A comprehensive toxicological safety assessment of an extract of Ageratum conyzoides. Regul Toxicol Pharmacol 2019; 103:140-149. [DOI: 10.1016/j.yrtph.2019.01.027] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2018] [Revised: 01/17/2019] [Accepted: 01/20/2019] [Indexed: 11/28/2022]
|
18
|
Thiel A, Glávits R, Murbach TS, Endres JR, Reddeman R, Hirka G, Vértesi A, Béres E, Szakonyiné IP. Toxicological evaluations of colostrum ultrafiltrate. Regul Toxicol Pharmacol 2019; 104:39-49. [PMID: 30831157 DOI: 10.1016/j.yrtph.2019.02.017] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2018] [Revised: 02/22/2019] [Accepted: 02/24/2019] [Indexed: 10/27/2022]
Abstract
Colostrum has been consumed safely for many years as a food collected directly from cows. More recently, an ultrafiltrated bovine colostrum product has been developed; however, its safety in toxicology studies has not been extensively evaluated. To assess the safety of bovine colostrum ultrafiltrate, in accordance with internationally accepted standards, the genotoxic potential was investigated in a bacterial reverse mutation test, an in vitro chromosomal aberration test, and an in vivo mammalian micronucleus test. No mutagenicity or genotoxic activity was observed in these three tests. A 90-day repeated-dose oral toxicity study in Hsd.Han Wistar rats was conducted at doses of 0, 1050, 2100, and 4200 mg/kg bw/day by gavage. After 90 days of continuous exposure, no mortality or treatment-related adverse effects were observed, and no target organs were identified. The no-observed-adverse-effect level (NOAEL) was determined to be 4200 mg/kg bw/day, the highest dose tested.
Collapse
Affiliation(s)
- Anne Thiel
- AIBMR Life Sciences, Inc., 2800 East Madison Street, Suite 202, Seattle, WA 98112, USA.
| | - Róbert Glávits
- Toxi-Coop Zrt, Magyar Jakobinusok Tere 4/B, H-1122 Budapest, Hungary.
| | - Timothy S Murbach
- AIBMR Life Sciences, Inc., 2800 East Madison Street, Suite 202, Seattle, WA 98112, USA.
| | - John R Endres
- AIBMR Life Sciences, Inc., 2800 East Madison Street, Suite 202, Seattle, WA 98112, USA.
| | - Robin Reddeman
- AIBMR Life Sciences, Inc., 2800 East Madison Street, Suite 202, Seattle, WA 98112, USA.
| | - Gábor Hirka
- Toxi-Coop Zrt, Magyar Jakobinusok Tere 4/B, H-1122 Budapest, Hungary.
| | - Adél Vértesi
- Toxi-Coop Zrt, Magyar Jakobinusok Tere 4/B, H-1122 Budapest, Hungary.
| | - Erzsébet Béres
- Toxi-Coop Zrt, Magyar Jakobinusok Tere 4/B, H-1122 Budapest, Hungary.
| | | |
Collapse
|
19
|
Leber A, Hontecillas R, Zoccoli-Rodriguez V, Ehrich M, Davis J, Chauhan J, Bassaganya-Riera J. Nonclinical Toxicology and Toxicokinetic Profile of an Oral Lanthionine Synthetase C-Like 2 (LANCL2) Agonist, BT-11. Int J Toxicol 2019; 38:96-109. [PMID: 30791754 DOI: 10.1177/1091581819827509] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
BT-11 is an orally active, gut-restricted investigational therapeutic targeting the lanthionine synthetase C-like 2 pathway with lead indications in ulcerative colitis (UC) and Crohn disease (CD), 2 manifestations of inflammatory bowel disease (IBD). In 5 mouse models of IBD, BT-11 is effective at oral doses of 8 mg/kg. BT-11 was also efficacious at nanomolar concentrations in primary human samples from patients with UC and CD. BT-11 was tested under Good Laboratory Practice conditions in 90-day repeat-dose general toxicity studies in rats and dogs, toxicokinetics, respiratory, cardiovascular and central nervous system safety pharmacology, and genotoxicity studies. Oral BT-11 did not cause any clinical signs of toxicity, biochemical or hematological changes, or macroscopic or microscopic changes to organs in 90-day repeat-dose toxicity studies in rats and dogs at doses up to 1,000 mg/kg/d. Oral BT-11 resulted in low systemic exposure in both rats (area under the curve exposure from t = 0 to t = 8 hours [AUC0-8] of 216 h × ng/mL) and dogs (650 h × ng/mL) and rapid clearance with an average half-life of 3 hours. BT-11 did not induce changes in respiratory function, electrocardiogram parameters, or behavior with single oral doses of 1,000 mg/kg/d. There was no evidence of mutagenic or genotoxic potential for BT-11 up to tested limit doses using an Ames test, chromosomal aberration assay in human peripheral blood lymphocytes, or micronucleus assay in rats. Therefore, nonclinical studies show BT-11 to be a safe and well-tolerated oral therapeutic with potential as a potent immunometabolic therapy for UC and CD with no-observed adverse effect level >1,000 mg/kg in in vivo studies.
Collapse
Affiliation(s)
| | | | | | - Marion Ehrich
- 2 Department of Biomedical Sciences & Pathobiology, Virginia Tech, Blacksburg, VA, USA
| | - Jennifer Davis
- 2 Department of Biomedical Sciences & Pathobiology, Virginia Tech, Blacksburg, VA, USA
| | | | | |
Collapse
|
20
|
Safety evaluation of xylanase 50316 enzyme preparation (also known as VR007), expressed in Pseudomonas fluorescens, intended for use in animal feed. Regul Toxicol Pharmacol 2018; 97:48-56. [DOI: 10.1016/j.yrtph.2018.05.016] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2017] [Revised: 05/25/2018] [Accepted: 05/28/2018] [Indexed: 11/21/2022]
|
21
|
Murbach TS, Glávits R, Endres JR, Hirka G, Vértesi A, Béres E, Szakonyiné IP. A Toxicological Evaluation of Chlamydomonas reinhardtii, a Green Algae. Int J Toxicol 2018; 37:53-62. [PMID: 29303016 DOI: 10.1177/1091581817746109] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
There is a current worldwide interest in developing novel sustainable nonanimal nutritional sources, and one such source is the green algae Chlamydomonas reinhardtii, the only green algae that has been studied as a model organism for many biological processes ranging from photosynthesis to flagellar movement. However, its potential as a safe nutritional source for use in various foods has not been thoroughly investigated. To assess the safety of C reinhardtii for use as a nutritional human food ingredient, in accordance with internationally accepted standards, the genotoxic potential and repeated-dose oral toxicity of the dried C reinhardtii (THN 6) algal biomass was investigated. The following studies were conducted: (1) a bacterial reverse mutation test, (2) an in vitro mammalian chromosomal aberration test, (3) an in vivo mammalian micronucleus test, and (4) a 28-day repeated-dose oral toxicity study in rats. No evidence of mutagenicity or genotoxic activity was observed in the first 3 tests under the applied test systems. In the 28-day study, male and female Hsd.Han Wistar rats were exposed to daily doses of 0, 1,000, 2,000, and 4,000 mg/kg bw by gavage. Following 28 days of continuous exposure, no mortality or treatment-related adverse effects were observed and no target organs were identified. Therefore, a no observed adverse effect level was concluded as 4,000 mg/kg bw/day, the highest dose tested.
Collapse
|
22
|
Liu Q, Lei Z, Zhu F, Ihsan A, Wang X, Yuan Z. A Novel Strategy to Predict Carcinogenicity of Antiparasitics Based on a Combination of DNA Lesions and Bacterial Mutagenicity Tests. Front Public Health 2017; 5:288. [PMID: 29170735 PMCID: PMC5684118 DOI: 10.3389/fpubh.2017.00288] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2017] [Accepted: 10/16/2017] [Indexed: 11/13/2022] Open
Abstract
Genotoxicity and carcinogenicity testing of pharmaceuticals prior to commercialization is requested by regulatory agencies. The bacterial mutagenicity test was considered having the highest accuracy of carcinogenic prediction. However, some evidences suggest that it always results in false-positive responses when the bacterial mutagenicity test is used to predict carcinogenicity. Along with major changes made to the International Committee on Harmonization guidance on genotoxicity testing [S2 (R1)], the old data (especially the cytotgenetic data) may not meet current guidelines. This review provides a compendium of retrievable results of genotoxicity and animal carcinogenicity of 136 antiparasitics. Neither genotoxicity nor carcinogenicity data is available for 84 (61.8%), while 52 (38.2%) have been evaluated in at least one genotoxicity or carcinogenicity study, and only 20 (14.7%) in both genotoxicity and carcinogenicity studies. Among 33 antiparasitics with at least one old result in in vitro genotoxicity, 15 (45.5%) are in agreement with the current ICH S2 (R1) guidance for data acceptance. Compared with other genotoxicity assays, the DNA lesions can significantly increase the accuracy of prediction of carcinogenicity. Together, a combination of DNA lesion and bacterial tests is a more accurate way to predict carcinogenicity.
Collapse
Affiliation(s)
- Qianying Liu
- MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, China
| | - Zhixin Lei
- National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, China
| | - Feng Zhu
- National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, China
| | - Awais Ihsan
- Department of Biosciences, COMSATS Institute of Information Technology, Sahiwal, Pakistan
| | - Xu Wang
- Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, China
| | - Zonghui Yuan
- MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, China
- National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, China
- Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, China
| |
Collapse
|
23
|
Croaker A, King GJ, Pyne JH, Anoopkumar-Dukie S, Simanek V, Liu L. Carcinogenic potential of sanguinarine, a phytochemical used in 'therapeutic' black salve and mouthwash. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH 2017; 774:46-56. [PMID: 29173498 DOI: 10.1016/j.mrrev.2017.09.001] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/26/2017] [Revised: 08/17/2017] [Accepted: 09/02/2017] [Indexed: 02/07/2023]
Abstract
Black salves are escharotic skin cancer therapies in clinical use since the mid 19th century. Sanguinaria canadensis, a major ingredient of black salve formulations, contains a number of bioactive phytochemicals including the alkaloid sanguinarine. Despite its prolonged history of clinical use, conflicting experimental results have prevented the carcinogenic potential of sanguinarine from being definitively determined. Sanguinarine has a molecular structure similar to known polyaromatic hydrocarbon carcinogens and is a DNA intercalator. Sanguinarine also generates oxidative and endoplasmic reticulum stress resulting in the unfolded protein response and the formation of 8-hydroxyguanine genetic lesions. Sanguinarine has been the subject of contradictory in vitro and in vivo genotoxicity and murine carcinogenesis test results that have delayed its carcinogenic classification. Despite this, epidemiological studies have linked mouthwash that contains sanguinarine with the development of oral leukoplakia. Sanguinarine is also proposed as an aetiological agent in gallbladder carcinoma. This literature review investigates the carcinogenic potential of sanguinarine. Reasons for contradictory genotoxicity and carcinogenesis results are explored, knowledge gaps identified and a strategy for determining the carcinogenic potential of sanguinarine especialy relating to black salve are discussed. As patients continue to apply black salve, especially to skin regions suffering from field cancerization and skin malignancies, an understanding of the genotoxic and carcinogenic potential of sanguinarine is of urgent clinical relevance.
Collapse
Affiliation(s)
- Andrew Croaker
- Southern Cross Plant Science, Southern Cross University, Lismore, NSW, Australia; Wesley Medical Research Institute, Wesley Hospital, Auchenflower, QLD, Australia; Quality Use of Medicines Network, Queensland, Australia
| | - Graham J King
- Southern Cross Plant Science, Southern Cross University, Lismore, NSW, Australia
| | - John H Pyne
- School of Medicine, University of Queensland, St Lucia, QLD, Australia
| | - Shailendra Anoopkumar-Dukie
- Quality Use of Medicines Network, Queensland, Australia; School of Pharmacy and Pharmacology, Griffith University, Gold Coast Campus, Gold Coast, QLD, Australia
| | - Vilim Simanek
- Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic
| | - Lei Liu
- Southern Cross Plant Science, Southern Cross University, Lismore, NSW, Australia.
| |
Collapse
|
24
|
Reflections on a career and on the history of genetic toxicity testing in the National Toxicology Program. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH 2017; 773:282-292. [DOI: 10.1016/j.mrrev.2017.03.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 02/09/2017] [Indexed: 11/20/2022]
|
25
|
Kulkarni RM, Dakoulas EW, Miller KE, Terse PS. Evaluation of genetic toxicity of 6-diazo-5-oxo-l-norleucine (DON). Toxicol Mech Methods 2017; 27:518-527. [PMID: 28552037 DOI: 10.1080/15376516.2017.1333552] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
DON (6-diazo-5-oxo-l-norleucine), a glutamine antagonist, was demonstrated to exhibit analgesic, antibacterial, antiviral and anticancer properties. The study was performed to characterize its in vitro and in vivo genetic toxicity potential. DON was tested in the bacterial reverse mutation assay (Ames test) using Salmonella typhimurium tester strains (TA98, TA100, TA1535 and TA1537) and Escherichia coli tester strain (WP2 uvrA) with and without S9 and also with reductive S9. In addition, DON was tested for the chromosome aberrations in Chinese hamster ovary (CHO) cells with or without S9 to evaluate the clastogenic potential. Furthermore, DON was also evaluated for its in vivo clastogenic activity by detecting micronuclei in polychromatic erythrocyte (PCE) cells in bone marrow collected from the male mice dosed intravenously with 500, 100, 10, 1 and 0.1 mg/kg at 24 and 48-h post-dose. The Ames mutagenicity assay showed no positive mutagenic responses. However, the in vitro chromosome aberration assay demonstrated dose dependent statistically positive increase in structural aberrations at 4 and 20-h exposure without S9 and also at 4-h exposure with S9. The in vivo micronucleus assay also revealed a statistically positive response for micronucleus formation at 500, 100 and 10 mg/kg at 24 and 48-h post-dose. Thus, DON appears to be negative in the Ames test but positive in the in vitro chromosome aberration assay and in the in vivo micronucleus assay. In conclusion, the results indicate DON is a genotoxic compound with a plausible epigenetic mechanism.
Collapse
Affiliation(s)
- Rohan M Kulkarni
- a BioReliance Corp., A MilliporeSigma Business , Rockville , MD , USA
| | - Emily W Dakoulas
- a BioReliance Corp., A MilliporeSigma Business , Rockville , MD , USA
| | | | - Pramod S Terse
- c National Center for Advancing Translational Sciences, NIH , Bethesda , MD , USA
| |
Collapse
|
26
|
Kour J, Ali MN, Ganaie HA, Tabassum N. Amelioration of the cyclophosphamide induced genotoxic damage in mice by the ethanolic extract of Equisetum arvense. Toxicol Rep 2017; 4:226-233. [PMID: 28959643 PMCID: PMC5615123 DOI: 10.1016/j.toxrep.2017.05.001] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2017] [Revised: 05/08/2017] [Accepted: 05/09/2017] [Indexed: 12/27/2022] Open
Abstract
Plants like E. arvense posess not only nutritional value but therapeutic value as well. CPA is an important chemotherapeutic agent but is associated with various mutagenic and other toxic side effects. Ethanolic extract of the plant has immense protective effect against the genotoxic damage induced by the cyclophosphamide. GC–MS analysis of the extract shows various important phyto components which may be associated with its antimutagenic property. Plant can be used in cancer as a chemopreventive agent or even as a coadjuvant to chemotherapy to reduce the side effects associated with it.
In the present study, we evaluated the potential of the plant E. arvense against the cytotoxic and mutagenic effects induced by cyclophosphamide (chemotherapeutic agent) in the bone marrow cells of mice using the Chromosome assay (CA) and Mitotic index (MI) in vivo as the biomarkers. The study was performed following 3 protocols: pre-treatment, simultaneous treatment and post-treatment with the ethanolic extract of the plant. The results demonstrated that the plant extract was not cytotoxic and mutagenic and has a protective effect against the mutagenicity induced by cyclophosphamide in pre, simultaneous and post treatments and against its cytotoxicity as well. Because of its ability to prevent chromosomal damage, E. arvense is likely to open an interesting field concerning its possible use in clinical applications, most importantly in cancer as a chemopreventive agent or even as a coadjuvant to chemotherapy to reduce the side effects associated with it.
Collapse
Affiliation(s)
- Jasbir Kour
- Cytogenetics & Molecular Biology Research Laboratory, Centre of Research for Development, University of Kashmir, Srinagar 190 006, JK, India
| | - Md Niamat Ali
- Cytogenetics & Molecular Biology Research Laboratory, Centre of Research for Development, University of Kashmir, Srinagar 190 006, JK, India
| | - Hilal Ahmad Ganaie
- Cytogenetics & Molecular Biology Research Laboratory, Centre of Research for Development, University of Kashmir, Srinagar 190 006, JK, India
| | - Nahida Tabassum
- Department of Pharmaceutical Sciences, University of Kashmir, Srinagar 190 006, JK, India
| |
Collapse
|
27
|
Souza TAJ, Franchi LP, Rosa LR, da Veiga MAMS, Takahashi CS. Cytotoxicity and genotoxicity of silver nanoparticles of different sizes in CHO-K1 and CHO-XRS5 cell lines. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS 2015; 795:70-83. [PMID: 26774669 DOI: 10.1016/j.mrgentox.2015.11.002] [Citation(s) in RCA: 69] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/20/2015] [Revised: 10/29/2015] [Accepted: 11/05/2015] [Indexed: 01/16/2023]
Abstract
Nanoparticles (NPs) have been used in a range of products due to their unique properties. Nevertheless, these NPs can cause adverse biological effects and because of that, there is a great concern about the health and environmental risks related to their use. Recently, silver nanoparticles (Ag NPs) have been used in a variety of cytotoxicity and genotoxicity studies, but there are still controversies regarding the association between the size and the toxicity of these particles. Therefore, in this study, we aimed to evaluate the cytotoxicity and genotoxicity of Ag NPs (10 and 100 nm) in two different cell lines, CHO-K1 and CHO-XRS5, by performing cell viability assay (XTT), clonogenic assay, micronucleus test, comet assay, as well as by investigating the cell cycle kinetics using the flow cytometry. Cell cultures were exposed to different concentrations of AgNPs (0.025-5.0 μg/ml) for 24 h. Our results indicated that cytotoxicity and genotoxicity induced by the 100 nm-Ag NPs were greater than those induced by the 10 nm-Ag NPs for both cell lines, which suggests that the exposure to greater size particles (100 nm) can cause more adverse biological effects than the exposure to the smaller ones (10 nm).
Collapse
Affiliation(s)
- Tiago A J Souza
- Department of Genetics, FMRP-USP, São Paulo University-USP, Ribeirão Preto, SP, Brazil.
| | - Leonardo P Franchi
- Department of Genetics, FMRP-USP, São Paulo University-USP, Ribeirão Preto, SP, Brazil
| | - Lilian R Rosa
- Departament of Chemistry, FFCLRP-USP, São Paulo University-USP, Ribeirão Preto, SP, Brazil
| | - Márcia A M S da Veiga
- Departament of Chemistry, FFCLRP-USP, São Paulo University-USP, Ribeirão Preto, SP, Brazil
| | - Catarina S Takahashi
- Department of Genetics, FMRP-USP, São Paulo University-USP, Ribeirão Preto, SP, Brazil; Departament of Biology, FFCLRP-USP, São Paulo University-USP, Ribeirão Preto, SP, Brazil
| |
Collapse
|
28
|
Murbach TS, Béres E, Vértesi A, Glávits R, Hirka G, Endres JR, Clewell AE, Szakonyiné IP. A comprehensive toxicological safety assessment of an aqueous extract of Polypodium leucotomos (Fernblock(®)). Food Chem Toxicol 2015; 86:328-41. [PMID: 26585922 DOI: 10.1016/j.fct.2015.11.008] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2015] [Revised: 11/02/2015] [Accepted: 11/05/2015] [Indexed: 12/01/2022]
Abstract
A battery of toxicological studies was conducted in accordance with internationally accepted standards to investigate the genotoxicity and repeated-dose oral toxicity of Fernblock(®), a commercial aqueous extraction of the leaves of the tropical fern Polypodium leucotomos used for its oral and topical photoprotective properties. No evidence of mutagenicity was observed in a bacterial reverse mutation test or in vitro mammalian chromosomal aberration test nor was any genotoxic activity observed in an in vivo mouse micronucleus test. Two repeated-dose oral toxicity studies were conducted in male and female Wistar rats. In the first study, no mortality or toxic effects were observed and no target organs were identified at doses administered for 14 days by gavage up to the maximum dose of 5000 mg/kg bw/day. Based on these results, a 90-day study was conducted at 0, 300, 600, and 1200 mg/kg bw/day. No mortality or treatment-related adverse effects were observed and no target organs were identified. The NOAEL from the 90-day study was determined to be 1200 mg/kg bw/day, the highest dose tested.
Collapse
Affiliation(s)
- Timothy S Murbach
- AIBMR Life Sciences, Inc., 4117 South Meridian, Puyallup, WA 98373, USA.
| | - Erzsébet Béres
- Toxi-Coop Zrt., Deres u. 10/A, H-1124 Budapest, Hungary.
| | - Adél Vértesi
- Toxi-Coop Zrt., Deres u. 10/A, H-1124 Budapest, Hungary.
| | - Róbert Glávits
- Toxi-Coop Zrt., Deres u. 10/A, H-1124 Budapest, Hungary.
| | - Gábor Hirka
- Toxi-Coop Zrt., Deres u. 10/A, H-1124 Budapest, Hungary.
| | - John R Endres
- AIBMR Life Sciences, Inc., 4117 South Meridian, Puyallup, WA 98373, USA.
| | - Amy E Clewell
- AIBMR Life Sciences, Inc., 4117 South Meridian, Puyallup, WA 98373, USA.
| | | |
Collapse
|
29
|
Krygier S, Solbak A, Shanahan D, Ciofalo V. Safety evaluation of phytase 50104 enzyme preparation (also known as VR003), expressed in Pseudomonas fluorescens, intended for increasing digestibility of phytate in monogastrics. Regul Toxicol Pharmacol 2014; 70:545-54. [PMID: 24945743 DOI: 10.1016/j.yrtph.2014.06.010] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2014] [Revised: 05/28/2014] [Accepted: 06/10/2014] [Indexed: 10/25/2022]
Abstract
Phytase 50104 enzyme (also known as VR003) can be added to swine and poultry diets to catalyze the hydrolysis of phosphate from phytic acid, thereby increasing phosphorus bioavailability in these animals. This enzyme was produced from a Pseudomonas fluorescens (P. fluorescens) production strain and was tested in acute, subchronic and genotoxicity studies. Dosages of the test article preparation ranged from 5000μg/plate for in vitro toxicity studies to 2000mg/kg/day for in vivo toxicity studies. The highest oral dose tested in vivo (NOAEL of 2000mg/kg/day) resulted in a safety margin of 5870 based on TOS and a conservative estimate of total poultry consumption at the highest inclusion rate. There was no toxicity reported for any of these studies or in the following additional safety studies: eye irritation, dermal irritation, and delayed hypersensitivity studies. A review of the public literature indicated that P. fluorescens fulfilled the recognized safety criteria pertinent to microbial production strains used in the manufacture of food/feed enzyme preparations. The results of the toxicity studies presented herein attest to the safety of phytase 50104 enzyme for its intended use.
Collapse
Affiliation(s)
- Scott Krygier
- Verenium Corporation, 3550 John Hopkins Ct, San Diego, CA 92121, USA
| | - Arne Solbak
- Verenium Corporation, 3550 John Hopkins Ct, San Diego, CA 92121, USA
| | - Diane Shanahan
- Verenium Corporation, 3550 John Hopkins Ct, San Diego, CA 92121, USA.
| | - Vince Ciofalo
- Shoreline Toxicology, LLC, 53 River Walk, Branford, CT 06405, USA.
| |
Collapse
|
30
|
Tripathi R, Tripathi P, Pancholi SS, Patel CN. The genotoxic and cytotoxic effects of nimesulide in the mouse bone marrow. Drug Chem Toxicol 2013; 37:255-60. [DOI: 10.3109/01480545.2013.838779] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
31
|
Atlı Şekeroğlu Z, Akar A, Şekeroğlu V. Evaluation of the cytogenotoxic damage in immature and mature rats exposed to 900 MHz radiofrequency electromagnetic fields. Int J Radiat Biol 2013; 89:985-92. [DOI: 10.3109/09553002.2013.809170] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
32
|
Effects of Viscum album L. extract and quercetin on methotrexate-induced cyto-genotoxicity in mouse bone-marrow cells. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS 2012; 746:56-9. [DOI: 10.1016/j.mrgentox.2012.02.012] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/09/2011] [Revised: 10/22/2011] [Accepted: 02/22/2012] [Indexed: 01/26/2023]
|
33
|
Sekeroğlu V, Akar A, Sekeroğlu ZA. Cytotoxic and genotoxic effects of high-frequency electromagnetic fields (GSM 1800 MHz) on immature and mature rats. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY 2012; 80:140-144. [PMID: 22405939 DOI: 10.1016/j.ecoenv.2012.02.028] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/06/2012] [Revised: 02/20/2012] [Accepted: 02/22/2012] [Indexed: 05/31/2023]
Abstract
We investigated the cytogenotoxic effects of high frequency electromagnetic fields (HF-EMF) for 45 day and the effect of a recovery period of 15 day after exposure to EMF on bone marrow cells of immature and mature rats. The animals in treatment groups were exposed to 1800 MHz EMF at SAR of 0.37 W/kg and 0.49 W/kg for 2h/day for 45 day. Two recovery groups were kept for a recovery period of 15 day without EMF after exposure to HF-EMF. Two control groups for both immature and mature rats were also included. Significant differences were also observed in chromosome aberrations (CA), micronucleus (MN) frequency, mitotic index (MI) and ratio of polychromatic erythrocytes (PCEs) in all treatment groups. The cytogenotoxic damage was more remarkable in immature rats and, the recovery period did not improve this damage in immature rats. Because much higher and irreversible cytogenotoxic damage was observed in immature rats than in mature rats, further studies are needed to understand effects of EMF on DNA damage and DNA repair, and to determine safe limits for environment and human, especially for children.
Collapse
Affiliation(s)
- Vedat Sekeroğlu
- Department of Biology, Faculty of Science and Letters, Ordu University, 52200 Ordu, Turkey.
| | | | | |
Collapse
|
34
|
Aydin B, Unsal M, Sekeroglu ZA, Gülbahar Y. The antioxidant and antigenotoxic effects of pycnogenol(®) on rats treated with cisplatin. Biol Trace Elem Res 2011; 142:638-50. [PMID: 20676799 DOI: 10.1007/s12011-010-8781-3] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/24/2010] [Accepted: 07/14/2010] [Indexed: 01/21/2023]
Abstract
Oxidative stress and inflammation are implicated in the pathogenesis of cisplatin-induced toxicity. Pycnogenol® is known for its strong antioxidant and anti-inflammatory effects. In this study, the possible protective effects of pycnogenol on kidney, bone marrow, and red blood cells in rats treated with cisplatin were investigated. The rats were divided into four groups. Group 1 was the control and groups 2, 3, and 4 were orally treated with pycnogenol (200 mg/kg bw, o.p) for 5 days, treated with cisplatin (7 mg/kg bw, i.p.) on the fifth day and treated with cisplatin plus pycnogenol, respectively. Antioxidative parameters in kidney and red blood cells were measured. Chromosome anomalies in bone marrow and renal histopathology were also investigated. Activities of pro-oxidant enzymes (myeloperoxidase and xanthine oxidase), malondialdehyde, and nitric oxide levels significantly increased but antioxidant enzymes activities decreased in the kidneys and red blood cells after cisplatin treatment. Pycnogenol treatment prior to the administration of cisplatin significantly decreased cisplatin-induced injury, as evidenced by its normalizing these parameters. Chromosomal aberrations decreased and mitotic index frequencies increased in bone marrow treated with cisplatin plus pycnogenol. These findings suggest that pycnogenol may be a useful protective agent against the toxicity associated with cisplatin therapy.
Collapse
Affiliation(s)
- Birsen Aydin
- Faculty of Science, Department of Biology, Amasya University, 05100 Amasya, Turkey.
| | | | | | | |
Collapse
|
35
|
Mara Serpeloni J, Mazzaron Barcelos GR, Prates Mori M, Yanagui K, Vilegas W, Aparecida Varanda E, de Syllos Cólus IM. Cytotoxic and mutagenic evaluation of extracts from plant species of the Miconia genus and their influence on doxorubicin-induced mutagenicity: An in vitro analysis. ACTA ACUST UNITED AC 2011; 63:499-504. [DOI: 10.1016/j.etp.2010.03.011] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2009] [Revised: 03/22/2010] [Accepted: 03/25/2010] [Indexed: 10/19/2022]
|
36
|
Kirkland D, Reeve L, Gatehouse D, Vanparys P. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. Mutat Res 2011; 721:27-73. [PMID: 21238603 DOI: 10.1016/j.mrgentox.2010.12.015] [Citation(s) in RCA: 161] [Impact Index Per Article: 12.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2010] [Revised: 11/12/2010] [Accepted: 12/15/2010] [Indexed: 01/27/2023]
Abstract
In vitro genotoxicity testing needs to include tests in both bacterial and mammalian cells, and be able to detect gene mutations, chromosomal damage and aneuploidy. This may be achieved by a combination of the Ames test (detects gene mutations) and the in vitro micronucleus test (MNvit), since the latter detects both chromosomal aberrations and aneuploidy. In this paper we therefore present an analysis of an existing database of rodent carcinogens and a new database of in vivo genotoxins in terms of the in vitro genotoxicity tests needed to detect their in vivo activity. Published in vitro data from at least one test system (most were from the Ames test) were available for 557 carcinogens and 405 in vivo genotoxins. Because there are fewer publications on the MNvit than for other mammalian cell tests, and because the concordance between the MNvit and the in vitro chromosomal aberration (CAvit) test is so high for clastogenic activity, positive results in the CAvit test were taken as indicative of a positive result in the MNvit where there were no, or only inadequate data for the latter. Also, because Hprt and Tk loci both detect gene-mutation activity, a positive Hprt test was taken as indicative of a mouse-lymphoma Tk assay (MLA)-positive, where there were no data for the latter. Almost all of the 962 rodent carcinogens and in vivo genotoxins were detected by an in vitro battery comprising Ames+MNvit. An additional 11 carcinogens and six in vivo genotoxins would apparently be detected by the MLA, but many of these had not been tested in the MNvit or CAvit tests. Only four chemicals emerge as potentially being more readily detected in MLA than in Ames+MNvit--benzyl acetate, toluene, morphine and thiabendazole--and none of these are convincing cases to argue for the inclusion of the MLA in addition to Ames+MNvit. Thus, there is no convincing evidence that any genotoxic rodent carcinogens or in vivo genotoxins would remain undetected in an in vitro test battery consisting of Ames+MNvit.
Collapse
Affiliation(s)
- David Kirkland
- Kirkland Consulting, PO Box 79, Tadcaster LS24 0AS, United Kingdom.
| | | | | | | |
Collapse
|
37
|
Alam SS, Hafiz NA, Abd El-Rahim AH. Protective role of taurine against genotoxic damage in mice treated with methotrexate and tamoxfine. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY 2011; 31:143-152. [PMID: 21787679 DOI: 10.1016/j.etap.2010.10.001] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/17/2010] [Revised: 10/01/2010] [Accepted: 10/04/2010] [Indexed: 05/31/2023]
Abstract
The genotoxic actions of anti-neoplastic drugs can lead to the development of secondary cancers in patients in extended remission. One of the most attractive approaches to disease prevention involves the use of natural antioxidants to protect tissue against toxic injury. We investigated the modulatory effects of exogenously administered taurine, on the genotoxicity of two well known anti-neoplastic drugs methotrexate (MTX) and tamoxifen (TAM) in Swiss albino mice. The animals were randomly divided into six groups consisting of ten mice each. Two groups were received single intraperitoneal injection of MTX (10 mg/kgb.wt.) and TAM (50 mg/kgb.wt.) to induce genotoxicity. Two other groups were treated orally with taurine (100 mg/kgb.wt.) for nine days prior to MTX and TAM administration. A vehicle treated control group and taurine control groups were also included. The protective effects of taurine were monitored by apoptosis assays and level of reduced glutathione (GSH), a key antioxidant, in liver, chromosomal aberrations in somatic and germ cells as well as sperm count, motility and morphology. The results indicated that taurine pre-treatment showed significant increment in the levels of GSH content, reduction in DNA fragmentation and ladder formation in hepatic tissue, suggesting the antioxidant activity of taurine may reduce the toxic effects of MTX and TAM. Treatment with taurine showed also significant reduction in the frequency of chromosomal aberrations in both somatic and germ cells. Moreover, it increases sperm count and motility, and decreases the incidence of sperm abnormalities. In conclusion, it appears that taurine protects against anti-neoplastic drugs-induced genotoxicity in somatic and germ tissues and may be of therapeutic potential in alleviating the risk of secondary tumors in chemotherapy.
Collapse
Affiliation(s)
- Sally S Alam
- Cell Biology Department, National Research Center, El Tahrir Street, 12622 Dokki, Giza, Egypt. dr
| | | | | |
Collapse
|
38
|
Tucker JD. Chromosome translocations and assessing human exposure to adverse environmental agents. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS 2010; 51:815-824. [PMID: 20213842 DOI: 10.1002/em.20561] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
This article discusses the use of chromosome translocations for assessing adverse environmental exposure in humans. Translocations are a persistent biomarker of exposure and a biomarker of effect, making them the endpoint of choice for certain human exposure studies because they indicate a potential relationship between exposure and adverse health outcomes, particularly cancer and birth defects. Presented here are the different types of translocations, their origins and persistence, the strengths and limitations of using translocations for exposure assessments, the current state of the art for quantifying exposure including the importance of confounding effects, and the use of model organisms. This article concludes with an assessment of the future of translocation analyses.
Collapse
Affiliation(s)
- James D Tucker
- Department of Biological Sciences, Wayne State University, Detroit, Michigan 48202-3917, USA.
| |
Collapse
|
39
|
Sazani P, Weller DL, Shrewsbury SB. Safety pharmacology and genotoxicity evaluation of AVI-4658. Int J Toxicol 2010; 29:143-56. [PMID: 20110565 DOI: 10.1177/1091581809359206] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Duchenne muscular dystrophy (DMD) is caused by dystrophin gene mutations. Restoration of dystrophin by exon skipping was demonstrated with the phosphorodiamidate morpholino oligomers (PMO) class of splice-switching oligomers, in both mouse and dog disease models. The authors report the results of Good Laboratory Practice-compliant safety pharmacology and genotoxicity evaluations of AVI-4658, a PMO under clinical evaluation for DMD. In cynomolgus monkeys, no test article-related effects were seen on cardiovascular, respiratory, global neurological, renal, or liver parameters at the maximum feasible dose (320 mg/kg). Genotoxicity battery showed that AVI-4658 has no genotoxic potential at up to 5000 microg/mL in an in vitro mammalian chromosome aberration test and a bacterial reverse mutation assay. In the mouse bone marrow erythrocyte micronucleus test, a single intravenous injection up to 2000 mg/kg was generally well tolerated and resulted in no mutagenic potential. These results allowed initiation of systemic clinical trials in DMD patients in the United Kingdom.
Collapse
|
40
|
Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH 2009; 681:209-229. [PMID: 18845271 DOI: 10.1016/j.mrrev.2008.09.002] [Citation(s) in RCA: 85] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/28/2007] [Revised: 09/09/2008] [Accepted: 09/10/2008] [Indexed: 11/24/2022]
|
41
|
Mun GC, Aardema MJ, Hu T, Barnett B, Kaluzhny Y, Klausner M, Karetsky V, Dahl EL, Curren RD. Further development of the EpiDerm™ 3D reconstructed human skin micronucleus (RSMN) assay. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS 2009; 673:92-9. [DOI: 10.1016/j.mrgentox.2008.12.004] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/10/2008] [Revised: 12/12/2008] [Accepted: 12/22/2008] [Indexed: 10/21/2022]
|
42
|
Das T, Choudhury AR, Sharma A, Talukder G. Modification of Cytotoxic Effects of Inorganic Arsenic by a Crude Extract of Allium sativum L. in Mice. ACTA ACUST UNITED AC 2008. [DOI: 10.3109/13880209309082960] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Affiliation(s)
- Tandra Das
- Genetic Toxicology Unit, Centre of Advanced Studies in Cell And Chromosome Research, Department of Botany, University of Calcutta, 35, Ballygunge Circular Road, Calcutta, 700019, India
| | - Arati Roy Choudhury
- Genetic Toxicology Unit, Centre of Advanced Studies in Cell And Chromosome Research, Department of Botany, University of Calcutta, 35, Ballygunge Circular Road, Calcutta, 700019, India
| | - Archana Sharma
- Genetic Toxicology Unit, Centre of Advanced Studies in Cell And Chromosome Research, Department of Botany, University of Calcutta, 35, Ballygunge Circular Road, Calcutta, 700019, India
| | - Geeta Talukder
- Vivekananda Institute of Medical Sciences, 99, Sarat Bose Road, Calcutta, 700026, India
| |
Collapse
|
43
|
Broccoli flower head extract reduces mitomycin-C induced sister chromatid exchange in cultured human lymphocytes. Food Chem Toxicol 2008; 46:3351-3. [PMID: 18775466 DOI: 10.1016/j.fct.2008.08.009] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2007] [Revised: 04/18/2008] [Accepted: 08/13/2008] [Indexed: 11/24/2022]
Abstract
This study is a continuation of our previous work [Murugan, S.S., Balakrishnamurthy, P., Mathew, Y.J., 2007. Antimutagenic effect of broccoli flower head by the Ames Salmonella reverse mutation assay. Phytother. Res. 21, 545-547], in search of possible antimutagenic properties in broccoli flower head extracts. In the present investigation, the effect of addition of ethanol extract of broccoli flower head on mitomycin-C (MMC) induced sister chromatid exchange (SCE) in cultured human peripheral blood lymphocytes was investigated. Broccoli flower head was extracted in ethanol using either acetone or ethanol as solvents. The extract was tested at final concentrations of 200 and 400 microg/ml culture and set for SCE assay. MMC at a concentration of 1 microg/ml and the test concentrations of broccoli flower head were added to the culture following 48 h from the initiation of culture. Enumeration of SCE in second division mitotic cells indicated that broccoli flower head extract significantly reduced MMC induced SCEs at both the concentrations tested. This observation is in line with our earlier finding and confirms to the presence of antimutagenic principles in broccoli flower head extract.
Collapse
|
44
|
Billinton N, Hastwell PW, Beerens D, Birrell L, Ellis P, Maskell S, Webster TW, Windebank S, Woestenborghs F, Lynch AM, Scott AD, Tweats DJ, van Gompel J, Rees RW, Walmsley RM. Interlaboratory assessment of the GreenScreen HC GADD45a-GFP genotoxicity screening assay: An enabling study for independent validation as an alternative method. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS 2008; 653:23-33. [DOI: 10.1016/j.mrgentox.2008.02.011] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/21/2007] [Revised: 01/21/2008] [Accepted: 02/14/2008] [Indexed: 10/22/2022]
|
45
|
Andrade LS, Santos DB, Castro DB, Guillo LA, Chen-Chen L. Absence of antimutagenicity of Cochlospermum regium (Mart. and Schr.) Pilger 1924 by micronucleus test in mice. BRAZ J BIOL 2008; 68:155-9. [DOI: 10.1590/s1519-69842008000100022] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2006] [Accepted: 04/18/2006] [Indexed: 11/22/2022] Open
Abstract
Cochlospermum regium (Mart. and Schr.) Pilger, popularly known as "algodãozinho do campo", is a medicinal plant that grows in the Cerrado of Brazil. This plant has been used in traditional medicine against various diseases such as leucorrhoea, gastritis and ulcers. It has also been effective in treating skin problems like pimples, boils and blotches. In the present study, the in vivo antimutagenicity of aqueous extract of C. regium was evaluated. The Micronucleus Test was performed in polychromatic erythrocytes from Swiss male mice treated with one of the four doses of extract of the plant (19, 38, 76 and 114 mg.kg-1 body weight), administered by intraperitonial injection (i.p.) simultaneously with cyclophosphamide (24 mg.kg-1 b.w.) or mitomycin C (4 mg.kg-1 b.w.). The cytotoxicity was evaluated by polychromatic and normochromatic erythrocytes ratio (PCE/NCE). The results showed no significant reduction of the micronucleated polychromatic erythrocytes frequency (P > 0.05). In conclusion, the data indicate that C. regium roots aqueous extract, for the conditions used, did not exhibit the antimutagenic effect.
Collapse
Affiliation(s)
| | | | | | - LA Guillo
- Universidade Federal de Goiás, Brazil
| | | |
Collapse
|
46
|
Vilar JB, Ferreira FL, Ferri PH, Guillo LA, Chen Chen L. Assessment of the mutagenic, antimutagenic and cytotoxic activities of ethanolic extract of araticum (Annona crassiflora Mart. 1841) by micronucleus test in mice. BRAZ J BIOL 2008; 68:141-7. [DOI: 10.1590/s1519-69842008000100020] [Citation(s) in RCA: 58] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2006] [Accepted: 05/16/2006] [Indexed: 01/01/2023] Open
Abstract
A typical Brazilian plant, araticum (Annona crassiflora Mart.), is widely used in humans as therapeutic medicine to treat several diseases such as diarrhea, rheumatism and syphilis. It contains acetogenins which present cytotoxic, antitumogenic, and antiparasitic properties. In this study, mutagenic, antimutagenic and cytotoxic effects of araticum leaves ethanolic extract were evaluated by micronucleus test in mice. To evaluate the mutagenic activity, animals were treated with ethanolic extract of araticum (EEA) using 10, 20, 50, 100 and 160 mg.kg-1. For all doses, micronucleated polychromatic erythrocytes (MNPCE) frequency was evaluated at 24, 48 and 72 hours after treatment. To evaluate the antimutagenic activity, animals were treated with 10, 20, 50 and 100 mg.kg-1 of EEA and 4 mg.kg-1 of MMC simultaneously. The frequency of MNPCE was evaluated 36 hours after exposure. Cytotoxicity was evaluated by the polychromatic and normochromatic erythrocytes ratio (PCE/NCE). In the mutagenicity assessment, all doses of EEA resulted in no significant increase of MNPCE (P > 0.05), compared to solvent- control group. Regarding administration time, no significant difference among three evaluation periods was observed (P > 0.05). Such results indicate that EEA did not exert mutagenic activity. Cytotoxicity was evident in doses of 50, 100 and 160 mg.kg-1 at 24 and 48 hours after exposure. Concerning antimutagenicity, except the 10 mg.kg-1 co-administered with 4 mg/kg of MMC, all doses reduced significantly the frequency of MNPCE compared to the positive control group (P < 0.05). These results, therefore, indicate an antimutagenic activity of the EEA. Cytotoxicity was significantly increased (P < 0.01) at 100 mg.kg-1 EEA doses co-administered with 4 mg.kg-1 of MMC.
Collapse
Affiliation(s)
- JB. Vilar
- Universidade Federal de Goiás, Brazil
| | | | | | | | | |
Collapse
|
47
|
Barcelos GRM, Shimabukuro F, Mori MP, Maciel MAM, Cólus IMDS. Evaluation of mutagenicity and antimutagenicity of cashew stem bark methanolic extract in vitro. JOURNAL OF ETHNOPHARMACOLOGY 2007; 114:268-73. [PMID: 17889467 DOI: 10.1016/j.jep.2007.08.006] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/11/2007] [Revised: 07/30/2007] [Accepted: 08/06/2007] [Indexed: 05/17/2023]
Abstract
Plants remain to be a great source of medicines for humanity. Among them is the Anacardium occidentale L. species, popularly known as the cashew, which has several therapeutic indications, such as cicatrizing, antihypertensive, hypoglycemic and antitumoral properties. The objective of the present work was to assess the mutagenicity and antimutagenicity of cashew stem bark methanolic extract (CSBME) on cell cultures of Chinese hamster lung fibroblasts (V79). The cultures were treated with different concentrations of the CSBME (500, 1000 and 2000 microg/mL) or with the extract associated with doxorubicin (DXR, 0.75 microg/mL) during the cell cycle phases G1, S, and G2 and throughout continuous treatment. Apart from these treatments, the cell cultures were also treated with PBS (negative-control) and DXR (positive-control). The data obtained in the chromosome aberrations (CA) test showed a significant reduction in CA frequency in the cultures treated with DXR and extract in comparison with those that received only DXR during the cell cycle phases G1 and S and throughout the entire cycle, as well as the absence of mutagenicity in all the treatments realized. The antimutagenic effect observed in this work reinforces the presence of the previously described therapeutic properties of cashew and indicates the safe use of this extract.
Collapse
Affiliation(s)
- Gustavo Rafael Mazzaron Barcelos
- Departamento de Biologia Geral, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Rodovia Celso Garcia Cid km 380, 86051-990 Londrina, Paraná, Brazil
| | | | | | | | | |
Collapse
|
48
|
Jha AM, Singh AC, Sinha U, Kumar M. Genotoxicity of crotonaldehyde in the bone marrow and germ cells of laboratory mice. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS 2007; 632:69-77. [PMID: 17543575 DOI: 10.1016/j.mrgentox.2007.04.008] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/07/2007] [Revised: 04/09/2007] [Accepted: 04/14/2007] [Indexed: 11/22/2022]
Abstract
Genotoxicity of crotonaldehyde was evaluated by employing bone marrow and spermatocyte chromosomal aberration and dominant lethal mutation assays in Swiss albino mice. For bone marrow chromosomal aberration assay, animals were treated with 0.2ml olive oil containing 8, 16 and 32microl kg b.w. of crotonaldehyde for 6, 12 and 24h through single intraperitoneal injection. Treatment induced dose-dependent and statistically significant decrease in mitotic index and increase in chromosome aberrations per cell (CAs/cell excluding gaps and stickiness and pulverizations) and percent aberrant metaphase (excluding gaps) in the bone marrow cells at 6, 12 and 24h after treatment. For spermatocyte chromosomal aberration assay, male mice were treated with 8, 16 and 32microl/kg b.w. of crotonaldehyde for 24h through single intraperitoneal injection. The percentage of the induced chromosome aberrations in diakinesis-metaphase-I cells showed dose-dependent increase. For dominant lethal mutation assay, adult male mice were injected intraperitoneally with 0.2ml olive oil containing crotonaldehyde at the rate of 8, 16 and 32microl/kg b.w. for 5 consecutive days. The negative control animals received 0.2ml olive oil as above. In the dominant lethal mutation assay after the last dose, the treated males were allowed to mate with untreated virgin females. The mating continued for 5 consecutive weeks. At pregnancy days 14-16, the females were killed and uterine contents were examined for live and dead implants. Treatment of mice resulted in statistically significant decrease in the fertility indices and total number of implants per female. Statistically significant decrease in the number of live implants per female and increase in the number of dead implants per female were recorded in females mated with males during 8-14 and 15-21 and 22-28 days post-treatment mating. Crotonaldehyde treatment of males induced appreciably higher frequencies of dominant lethal mutation during 8-14, 15-21 and 22-28 days post-treatment mating periods. Percent dominant lethal mutation increased concomitantly with the dose. Dominant lethality was maximum in females mated with males treated with 5x32microl/kg b.w. during the 15-21 days post-treatment mating. The overall result suggests a positive dose-response relationship between treatment and induction of chromosomal aberrations in the somatic and germ cells and dominant lethal mutation in the germ cells.
Collapse
Affiliation(s)
- Anand M Jha
- Genetic Toxicology Laboratory, Department of Biotechnology, Samastipur College, Samastipur 848134, India.
| | | | | | | |
Collapse
|
49
|
Sousa FG, Schneider NF, Mendes CE, de Moura NF, Denardin RB, Matuo R, Mantovani MS. Clastogenic and Anticlastogenic Effect of the Essential Oil fromCasearia sylvestrisSwart. JOURNAL OF ESSENTIAL OIL RESEARCH 2007. [DOI: 10.1080/10412905.2007.9699309] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
50
|
Maire MA, Rast C, Landkocz Y, Vasseur P. 2,4-Dichlorophenoxyacetic acid: effects on Syrian hamster embryo (SHE) cell transformation, c-Myc expression, DNA damage and apoptosis. Mutat Res 2007; 631:124-36. [PMID: 17540612 DOI: 10.1016/j.mrgentox.2007.03.008] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2006] [Revised: 01/16/2007] [Accepted: 03/23/2007] [Indexed: 11/25/2022]
Abstract
2,4-Dichlorophenoxyacetic acid (2,4-D) is a selective, systemic auxin-type herbicide extensively used throughout the world. The present research was aimed at studying effects of low and non-cytotoxic concentrations of 2,4-D on SHE cells in relation with carcinogenicity. Effects were studied on Syrian hamster morphological cell transformation, c-Myc expression - both at the gene and protein level - DNA damage and apoptosis. 2,4-D significantly induced cell transformation at 11.5 microM and 23 microM (i.e. 2.5 microg/mL and 5 microg/mL). An increase in the expression of the transcription factor c-Myc, measured by use of RT-PCR with respect to mRNA level and by Western blotting for protein level was registered at these concentrations, as well as genotoxic effects evaluated with the single-cell gel electrophoresis (Comet) assay. Consequences for apoptosis of 2,4-D treatment were also investigated. The fluorochrome acridine orange was used to study DNA fragmentation as a marker of apoptosis. No effect on apoptosis was found at 2,4-D concentrations that induced cell transformation. This was confirmed by the unchanged expression of Bcl-2 and Bax, two regulator genes of the mitochondrial pathway of apoptosis. Our results demonstrate the transforming and genotoxic effects of low concentrations of 2,4-D in mammalian cells. This information contributes to a better understanding of the mechanism of 2,4-D toxicity in mammalian cells and demonstrates that 2,4-D should be considered as potentially hazardous to humans.
Collapse
Affiliation(s)
- M A Maire
- Laboratoire Ecotoxicité Santé Environnementale, CNRS UMR 7146, Université de Metz, UFR Sciences Fondamentales et Appliquées, Rue Général Delestraint, 57070 Metz, France
| | | | | | | |
Collapse
|